Selumetinib in Children with BRAF-Aberrant or Neurofibromatosis type 1-Associated Recurrent, Refractory or Progressive Low-Grade Glioma: a Multi-Center Phase II Trial
485 citations
FWCI 36.50
Neurofibromatosis and Schwannoma Cases
Trend
Citation data as of 2026-04-12 (OpenAlex).
Extracted findings
This paper hasn't been extracted into the knowledge graph yet. We're working through the corpus — 6628202 is in the queue.